FAQs

• How is STADA positioned strategically?
• What are STADA’s specific strengths?
• What are the main risks for STADA?
• How does STADA consider the Corporate Governance Code?
• What STADA securities are available?
• On which stock indexes and segments is the STADA share listed?
• What does STADA’s shareholder structure look like?
• Stock statistics
• What dividend was decided for fiscal year 2009?
• What retroactive impact does the the changed accounting treatment of BIOCEUTICALS Arzneimittel AG pursuant to IAS 8 have on the consolidated balance sheet and income statement?
• What are the key figures for the STADA Group?
  • Overview of consolidated key figures
  • Key figures for the Group on a quarterly basis
  • STADA's sales in recent years
  • STADA's regional sales in recent years
  • STADA's sales by region and segment
  • STADA's earnings in recent years
  • STADA's employees
• How does STADA assess its business prospects?
• How are the earnings per share and the diluted earnings per share calculated?
• What influence do the existing STADA warrants and/or their conversion have on the number of STADA shares?
• What factors do shareholders need to consider with regard to STADA's July 2004 capital increase from its own funds and issuance of bonus shares? How are the earnings per share and the diluted earnings per share calculated?
• What is the best way to get up-to-date news about STADA on a regular basis?
• How can investors contact STADA?